EUVIMEDEUVIMED entdecken
Vergleichsstudie

Clinical outcomes of indwelling needle-delivered urokinase thrombolysis in the treatment of thrombosed arteriovenous grafts

Yu Zhou, Wenqin Li, Bo Chen, Ling Chen, Qiquan Lai, Bo Tu, Ziming Wan iD, Qinghua Zhao

The Journal of Vascular Access · 2024

DOI: 10.1177/11297298231191368 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Journal of Vascular Access, 2024. Verfasst von Yu Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Urokinase-Type Plasminogen Activator, Arteriovenous Shunt, Surgical, Vascular Patency, Thrombolytic Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: The Promotion Project of Appropriate Health Technologies of Chongqing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate the clinical outcomes of indwelling needle-delivered local urokinase thrombolysis, a cost-saving thrombolytic approach, in the treatment of thrombosed arteriovenous grafts (AVGs).

Methods

The clinical data of 71 patients with a first episode of thrombosed AVG were analyzed. Among them, 49 patients underwent urokinase thrombolysis and percutaneous transluminal angioplasty (PTA), and 22 patients underwent thrombectomy and PTA. The operation success rate, operation time, perioperative and postoperative complications, primary patency, and secondary patency were compared.

Results

Clinical success was achieved in all 71 PTAs. After thrombolysis, 29 patients achieved complete lysis, and 20 patients achieved partial lysis. All patients achieved thrombus clearance after PTA. The operating room usage time was 37.48 ± 5.33 min for the complete thrombolysis group and 41.70 ± 6.16 min for the incomplete thrombolysis group, and these values were not significantly different (p = 0.853). The operating room usage time of the thrombectomy group was 124.73 ± 5.08 min, which was significantly longer than that of the other groups (p < 0.001). The log-rank test indicated no significant difference in the 90-, 180-, and 360-day primary patency and corresponding secondary patency (all p > 0.05). The Cox regression showed that no significant difference was noted in the changing rate of primary or secondary patency among the groups (all p > 0.05). No major complications occurred in any of the groups, and the difference in the complication incidence was not significant (p = 0.336).

Conclusions

Indwelling needle-delivered urokinase thrombolysis is an acceptable method for the treatment of thrombosed AVGs. Compared with thrombectomy and PTA, thrombolysis and PTA can significantly shorten the time to use the operating room without reducing primary and secondary patency or increasing complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urokinase-Type Plasminogen ActivatorArteriovenous Shunt, SurgicalVascular PatencyThrombolytic TherapyThrombectomyFibrinolytic AgentsRenal DialysisGraft Occlusion, VascularNeedlesThrombosisHumansFemaleMaleMiddle AgedTreatment OutcomeTime FactorsAgedRetrospective StudiesRisk FactorsAdultAngioplasty, BalloonBlood Vessel Prosthesis ImplantationOperative Time

Stichwörter der Autor:innen

Indwelling needlearteriovenous graftrevascularizationthrombectomythrombolysis

Substanzen

Urokinase-Type Plasminogen ActivatorFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Ultrasonography, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Department of Nursing, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Ziming Wan

Förderung

  • The Promotion Project of Appropriate Health Technologies of Chongqing Municipality

Zitieren

APA

Zhou, Y., Li, W., Chen, B., Chen, L., Lai, Q., Tu, B., Wan, Z., & Zhao, Q. (2024). Clinical outcomes of indwelling needle-delivered urokinase thrombolysis in the treatment of thrombosed arteriovenous grafts. The Journal of Vascular Access. https://doi.org/10.1177/11297298231191368

Vancouver

Zhou Y, Li W, Chen B, Chen L, Lai Q, Tu B, et al. Clinical outcomes of indwelling needle-delivered urokinase thrombolysis in the treatment of thrombosed arteriovenous grafts. The Journal of Vascular Access. 2024. doi:10.1177/11297298231191368

BibTeX
@article{Zhou2024,
  author = {Zhou, Yu and Li, Wenqin and Chen, Bo and Chen, Ling and Lai, Qiquan and Tu, Bo and Wan, Ziming and Zhao, Qinghua},
  title = {Clinical outcomes of indwelling needle-delivered urokinase thrombolysis in the treatment of thrombosed arteriovenous grafts},
  journal = {The Journal of Vascular Access},
  year = {2024},
  doi = {10.1177/11297298231191368}
}
Kostenlos starten →